siRNA treatment decreases triglycerides in individuals along with rare condition
.ANALYSIS HIGHLIGHT.19 September 2024.
Plozasiran decreased triglyceride levels by 80% and decreased the risk of pancreatitis in people with constant chylomicronemia, with or without a hereditary medical diagnosis.